iotrolan has been researched along with Hypertension, Pulmonary in 1 studies
iotrolan: nonionic, isotonic contrast medium designed for intrathecal use; RN given refers to cpd without isomeric designation; DL-3-117 refers to stereoisomer; structure given in first source
Hypertension, Pulmonary: Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Emery, CJ | 1 |
| Fang, L | 1 |
| Laude, EA | 1 |
| Morcos, SK | 1 |
1 other study available for iotrolan and Hypertension, Pulmonary
| Article | Year |
|---|---|
Effects of radiographic contrast media on pulmonary vascular resistance of normoxic and chronically hypoxic pulmonary hypertensive rats.
Topics: Analysis of Variance; Animals; Contrast Media; Diatrizoate; Hypertension, Pulmonary; Hypoxia; Iohexo | 2001 |